Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Evidence of regio-specific glycosylation in human intestinal mucins: presence of an acidic gradient along the intestinal tract.

Robbe C, Capon C, Maes E, Rousset M, Zweibaum A, Zanetta JP, Michalski JC.

J Biol Chem. 2003 Nov 21;278(47):46337-48. Epub 2003 Sep 2.

2.

Postmitotic differentiation of colon carcinoma caco-2 cells does not prevent reentry in the cell cycle and tumorigenicity.

Pandrea IV, Carrière V, Barbat A, Cambier D, Dussaulx E, Lesuffleur T, Rousset M, Zweibaum A.

Exp Mol Pathol. 2000 Aug;69(1):37-45.

PMID:
10891291
3.

Massive in vitro synthesis of tagged oligosaccharides in 1-benzyl-2-acetamido-2-deoxy-alpha-D-galactopyranoside treated HT-29 cells.

Zanetta JP, Gouyer V, Maes E, Pons A, Hemon B, Zweibaum A, Delannoy P, Huet G.

Glycobiology. 2000 Jun;10(6):565-75.

PMID:
10814698
4.

Development of an endogenous epithelial Na(+)/H(+) exchanger (NHE3) in three clones of caco-2 cells.

Janecki AJ, Montrose MH, Tse CM, de Medina FS, Zweibaum A, Donowitz M.

Am J Physiol. 1999 Aug;277(2):G292-305. doi: 10.1152/ajpgi.1999.277.2.G292.

PMID:
10444443
5.

Decreased expression of gamma-glutamyltranspeptidase in the intestinal cell line Caco-2 by inducers of cytochrome P450 1A1.

Carrière V, Dussaulx E, Rousset M, Zweibaum A, Cambier D.

Biochem Pharmacol. 1998 Oct 1;56(7):817-23.

PMID:
9774143
6.

Hypoxia and CYP1A1 induction-dependent regulation of proteins involved in glucose utilization in Caco-2 cells.

Carrière V, Rodolosse A, Lacasa M, Cambier D, Zweibaum A, Rousset M.

Am J Physiol. 1998 Jun;274(6):G1101-8. doi: 10.1152/ajpgi.1998.274.6.G1101.

PMID:
9696711
7.

Permanent exposure of mucin-secreting HT-29 cells to benzyl-N-acetyl-alpha-D-galactosaminide induces abnormal O-glycosylation of mucins and inhibits constitutive and stimulated MUC5AC secretion.

Hennebicq-Reig S, Lesuffleur T, Capon C, De Bolos C, Kim I, Moreau O, Richet C, Hémon B, Recchi MA, Maës E, Aubert JP, Real FX, Zweibaum A, Delannoy P, Degand P, Huet G.

Biochem J. 1998 Aug 15;334 ( Pt 1):283-95.

8.

GalNAc-alpha-O-benzyl inhibits NeuAcalpha2-3 glycosylation and blocks the intracellular transport of apical glycoproteins and mucus in differentiated HT-29 cells.

Huet G, Hennebicq-Reig S, de Bolos C, Ulloa F, Lesuffleur T, Barbat A, Carrière V, Kim I, Real FX, Delannoy P, Zweibaum A.

J Cell Biol. 1998 Jun 15;141(6):1311-22.

9.

Selecting agent hygromycin B alters expression of glucose-regulated genes in transfected Caco-2 cells.

Rodolosse A, Barbat A, Chantret I, Lacasa M, Brot-Laroche E, Zweibaum A, Rousset M.

Am J Physiol. 1998 May;274(5):G931-8. doi: 10.1152/ajpgi.1998.274.5.G931.

PMID:
9612275
11.

Resistance to high concentrations of methotrexate and 5-fluorouracil of differentiated HT-29 colon-cancer cells is restricted to cells of enterocytic phenotype.

Lesuffleur T, Violette S, Vasile-Pandrea I, Dussaulx E, Barbat A, Muleris M, Zweibaum A.

Int J Cancer. 1998 May 4;76(3):383-92.

12.
13.

MUC1 mucin gene, transcripts, and protein in adenomas and papillary carcinomas of the thyroid.

Bièche I, Ruffet E, Zweibaum A, Vildé F, Lidereau R, Franc B.

Thyroid. 1997 Oct;7(5):725-31.

PMID:
9349575
14.

Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis.

Mallo GV, Rechreche H, Frigerio JM, Rocha D, Zweibaum A, Lacasa M, Jordan BR, Dusetti NJ, Dagorn JC, Iovanna JL.

Int J Cancer. 1997 Feb 20;74(1):35-44.

15.

Glucose-dependent transcriptional regulation of the human sucrase-isomaltase (SI) gene.

Rodolosse A, Carrière V, Chantret I, Lacasa M, Zweibaum A, Rousset M.

Biochimie. 1997 Feb-Mar;79(2-3):119-23.

PMID:
9209707
16.

Alteration in mucin gene expression and biological properties of HT29 colon cancer cell subpopulations.

Kitamura H, Cho M, Lee BH, Gum JR, Siddiki BB, Ho SB, Toribara NW, Lesuffleur T, Zweibaum A, Kitamura Y, Yonezawa S, Kim YS.

Eur J Cancer. 1996 Sep;32A(10):1788-96.

PMID:
8983291
17.

Regulation of sucrase-isomaltase and hexose transporters in Caco-2 cells: a role for cytochrome P-4501A1?

Carrière V, Barbat A, Rousset M, Brot-Laroche E, Dussaulx E, Cambier D, De Waziers ID, Beaune P, Zweibaum A.

Am J Physiol. 1996 Jun;270(6 Pt 1):G976-86.

PMID:
8764205
18.

A limited upstream region of the human sucrase-isomaltase gene confers glucose-regulated expression on a heterologous gene.

Rodolosse A, Chantret I, Lacasa M, Chevalier G, Zweibaum A, Swallow D, Rousset M.

Biochem J. 1996 Apr 1;315 ( Pt 1):301-6.

19.

Deregulation of hexose transporter expression in Caco-2 cells by ras and polyoma middle T oncogenes.

Baron-Delage S, Mahraoui L, Cadoret A, Veissiere D, Taillemite JL, Chastre E, Gespach C, Zweibaum A, Capeau J, Brot-Laroche E, Cherqui G.

Am J Physiol. 1996 Feb;270(2 Pt 1):G314-23.

PMID:
8779974
20.

Characterization of a mucin cDNA clone isolated from HT-29 mucus-secreting cells. The 3' end of MUC5AC?

Lesuffleur T, Roche F, Hill AS, Lacasa M, Fox M, Swallow DM, Zweibaum A, Real FX.

J Biol Chem. 1995 Jun 9;270(23):13665-73.

21.

Modifications of the anti-oxidant metabolism during proliferation and differentiation of colon tumor cell lines.

Bravard A, Beaumatin J, Dussaulx E, Lesuffleur T, Zweibaum A, Luccioni C.

Int J Cancer. 1994 Dec 15;59(6):843-7.

PMID:
7989127
22.

Expression of cytochrome P-450 3A in HT29-MTX cells and Caco-2 clone TC7.

Carrière V, Lesuffleur T, Barbat A, Rousset M, Dussaulx E, Costet P, de Waziers I, Beaune P, Zweibaum A.

FEBS Lett. 1994 Dec 5;355(3):247-50. Erratum in: FEBS Lett 1995 Mar 27;362(1):99.

23.

Mucins in normal and neoplastic human gastrointestinal tissues.

Lesuffleur T, Zweibaum A, Real FX.

Crit Rev Oncol Hematol. 1994 Dec;17(3):153-80. Review. No abstract available.

PMID:
7865137
24.

Presence and differential expression of SGLT1, GLUT1, GLUT2, GLUT3 and GLUT5 hexose-transporter mRNAs in Caco-2 cell clones in relation to cell growth and glucose consumption.

Mahraoui L, Rodolosse A, Barbat A, Dussaulx E, Zweibaum A, Rousset M, Brot-Laroche E.

Biochem J. 1994 Mar 15;298 Pt 3:629-33.

25.

Differential expression of sucrase-isomaltase in clones isolated from early and late passages of the cell line Caco-2: evidence for glucose-dependent negative regulation.

Chantret I, Rodolosse A, Barbat A, Dussaulx E, Brot-Laroche E, Zweibaum A, Rousset M.

J Cell Sci. 1994 Jan;107 ( Pt 1):213-25.

26.

Differential expression of the human mucin genes MUC1 to MUC5 in relation to growth and differentiation of different mucus-secreting HT-29 cell subpopulations.

Lesuffleur T, Porchet N, Aubert JP, Swallow D, Gum JR, Kim YS, Real FX, Zweibaum A.

J Cell Sci. 1993 Nov;106 ( Pt 3):771-83.

27.

[Differentiation of human colon cancer cells: a new approach to cancer of the colon].

Zweibaum A.

Ann Gastroenterol Hepatol (Paris). 1993 Oct;29(5):257-61; discussion 261-2. Review. French.

PMID:
8250521
28.

cis-Golgi resident proteins and O-glycans are abnormally compartmentalized in the RER of colon cancer cells.

Egea G, Francí C, Gambús G, Lesuffleur T, Zweibaum A, Real FX.

J Cell Sci. 1993 Jul;105 ( Pt 3):819-30.

29.

[Differentiation of human colon cancer cells: a new approach to colon cancer].

Zweibaum A.

Bull Acad Natl Med. 1993 Jan;177(1):63-71; discussion 71-3. Review. French.

PMID:
8319114
30.

Expression and characterization of mucins associated with the resistance to methotrexate of human colonic adenocarcinoma cell line HT29.

Dahiya R, Lesuffleur T, Kwak KS, Byrd JC, Barbat A, Zweibaum A, Kim YS.

Cancer Res. 1992 Sep 1;52(17):4655-62.

31.

Expression and localization of GLUT-5 in Caco-2 cells, human small intestine, and colon.

Mahraoui L, Rousset M, Dussaulx E, Darmoul D, Zweibaum A, Brot-Laroche E.

Am J Physiol. 1992 Sep;263(3 Pt 1):G312-8.

PMID:
1384349
32.

Dihydrofolate reductase gene amplification-associated shift of differentiation in methotrexate-adapted HT-29 cells.

Lesuffleur T, Barbat A, Luccioni C, Beaumatin J, Clair M, Kornowski A, Dussaulx E, Dutrillaux B, Zweibaum A.

J Cell Biol. 1991 Dec;115(5):1409-18.

33.

Synthesis and secretion of a cobalamin-binding protein by HT 29 cell line.

Schohn H, Guéant JL, Girr M, Nexø E, Baricault L, Zweibaum A, Nicolas JP.

Biochem J. 1991 Dec 1;280 ( Pt 2):427-30.

34.

Increased growth adaptability to 5-fluorouracil and methotrexate of HT-29 sub-populations selected for their commitment to differentiation.

Lesuffleur T, Kornowski A, Augeron C, Dussaulx E, Barbat A, Laboisse C, Zweibaum A.

Int J Cancer. 1991 Nov 11;49(5):731-7.

PMID:
1937959
35.

Adaptation to 5-fluorouracil of the heterogeneous human colon tumor cell line HT-29 results in the selection of cells committed to differentiation.

Lesuffleur T, Kornowski A, Luccioni C, Muleris M, Barbat A, Beaumatin J, Dussaulx E, Dutrillaux B, Zweibaum A.

Int J Cancer. 1991 Nov 11;49(5):721-30.

PMID:
1937958
37.

N-glycosylation modification of proteins is an early marker of the enterocytic differentiation process of HT-29 cells.

Ogier-Denis E, Bauvy C, Aubery M, Codogno P, Sapin C, Darmoul D, Zweibaum A, Trugnan G.

Reprod Nutr Dev. 1990;30(3):325-30.

38.

Reversible forskolin-induced impairment of sucrase-isomaltase mRNA levels, biosynthesis, and transport to the brush border membrane in Caco-2 cells.

Rousset M, Chantret I, Darmoul D, Trugnan G, Sapin C, Green F, Swallow D, Zweibaum A.

J Cell Physiol. 1989 Dec;141(3):627-35.

PMID:
2592430
39.

Processing of asparagine-linked oligosaccharides is an early biochemical marker of the enterocytic differentiation of HT-29 cells.

Ogier-Denis E, Bauvy C, Aubery M, Codogno P, Sapin C, Rousset M, Zweibaum A, Trugnan G.

J Cell Biochem. 1989 Sep;41(1):13-23.

PMID:
2592437
40.

Sucrase-isomaltase expression and enterocytic ultrastructure of human colorectal tumors.

Czernichow B, Simon-Assmann P, Kedinger M, Arnold C, Parache M, Marescaux J, Zweibaum A, Haffen K.

Int J Cancer. 1989 Aug 15;44(2):238-44.

PMID:
2759730
41.

Monensin inhibits the expression of sucrase-isomaltase in Caco-2 cells at the mRNA level.

Chantret I, Trugnan G, Dussaulx E, Zweibaum A, Rousset M.

FEBS Lett. 1988 Aug 1;235(1-2):125-8.

42.
43.

Development of vasoactive intestinal peptide-responsive adenylate cyclase during enterocytic differentiation of Caco-2 cells in culture. Evidence for an increased receptor level.

Laburthe M, Rousset M, Rouyer-Fessard C, Couvineau A, Chantret I, Chevalier G, Zweibaum A.

J Biol Chem. 1987 Jul 25;262(21):10180-4.

44.

The posttranslational processing of sucrase-isomaltase in HT-29 cells is a function of their state of enterocytic differentiation.

Trugnan G, Rousset M, Chantret I, Barbat A, Zweibaum A.

J Cell Biol. 1987 May;104(5):1199-205.

45.
47.

Castanospermine: a potent inhibitor of sucrase from the human enterocyte-like cell line Caco-2.

Trugnan G, Rousset M, Zweibaum A.

FEBS Lett. 1986 Jan 20;195(1-2):28-32.

48.

Can villin be used to identify malignant and undifferentiated normal digestive epithelial cells?

Robine S, Huet C, Moll R, Sahuquillo-Merino C, Coudrier E, Zweibaum A, Louvard D.

Proc Natl Acad Sci U S A. 1985 Dec;82(24):8488-92.

49.

Enterocytic differentiation and glucose utilization in the human colon tumor cell line Caco-2: modulation by forskolin.

Rousset M, Laburthe M, Pinto M, Chevalier G, Rouyer-Fessard C, Dussaulx E, Trugnan G, Boige N, Brun JL, Zweibaum A.

J Cell Physiol. 1985 Jun;123(3):377-85.

PMID:
2985631
50.

The intracellular accumulation of UDP-N-acetylhexosamines is concomitant with the inability of human colon cancer cells to differentiate.

Wice BM, Trugnan G, Pinto M, Rousset M, Chevalier G, Dussaulx E, Lacroix B, Zweibaum A.

J Biol Chem. 1985 Jan 10;260(1):139-46.

Supplemental Content

Loading ...
Support Center